TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
TPTX
Delisted
TPTX was delisted on the 16th of August, 2022.
158 hedge funds and large institutions have $2.4B invested in Turning Point Therapeutics, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 63 increasing their positions, 29 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more call options, than puts
Call options by funds: $6K | Put options by funds: $6K
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
158
Holding in Top 10
2
Calls
$6K
Puts
$6K
Top Buyers
| 1 | +$50.4M | |
| 2 | +$47.4M | |
| 3 | +$44.9M | |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$37.8M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$36.5M |
Top Sellers
| 1 | -$20.6M | |
| 2 | -$14.5M | |
| 3 | -$11.5M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$10.5M |
| 5 |
VP
venBio Partners
San Francisco,
California
|
-$7.16M |